IPHARMA, the partner of "Skolkovo" Innovative Center, is a fast-growing CRO in Russia and EAEU. Our mission is to contribute to progress of treating patients with socially significant and other important diseases by efficient organization of clinical studies and introduction of novel drugs to medical practice. Our pipeline consists of over 150 clinical studies in various therapeutic areas including oncology, HIV, HCV, diabetes, bronchial asthma, rheumatoid arthritis, schizophrenia, Alzheimer's disease and many others. We provide efficient clinical trial solutions in both early-phase and registration studies, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development and market access. According to Association of Clinical Trial Organizations (ACTO), IPHARMA has been ranked as a top Russian CRO (ACTO Analytical reports 2013-2018). Advantages of working with IPHARMA: 1. Full-service CRO + study design, medical writing, + regulatory, project management, logistics + site management, patient recruitment, monitoring, + DM, biostats, medical monitoring, + MAA, PV, QA. 2. Internal medical expertise and access to KOLs 3. Shortest timelines guaranteed 4. Qualified clinical staff + MD / PharmD / MSc, + >20% PhD, + 8 years in clinical research on average. 5. Quality management system in accordance with ICH GCP & GVP.